Published in HPB (Oxford) on December 12, 2011
Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr (2014) 1.18
Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality. World J Surg (2014) 0.98
Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol (2012) 0.97
Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg (2014) 0.97
Effects of introducing an enhanced recovery after surgery programme for patients undergoing open hepatic resection. HPB (Oxford) (2012) 0.93
Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics. J Gastroenterol (2012) 0.92
Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol (2014) 0.90
Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol (2013) 0.88
Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis (2014) 0.88
Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma. World J Surg (2013) 0.81
Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin. HPB (Oxford) (2013) 0.81
Serum albumin predicts survival in patients with hilar cholangiocarcinoma. Gastroenterol Rep (Oxf) (2016) 0.78
Radiological Imaging for Assessing the Respectability of Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Biomed Res Int (2015) 0.78
The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World J Surg (2015) 0.78
Perioperative Management of Hilar Cholangiocarcinoma. J Gastrointest Surg (2015) 0.77
Multimodal treatment strategies for advanced hilar cholangiocarcinoma. Langenbecks Arch Surg (2014) 0.76
Bile duct surgery in the treatment of hepatobiliary and gallbladder malignancies: effects of hepatic and vascular resection on outcomes. HPB (Oxford) (2015) 0.75
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES. Am J Med (1965) 4.22
Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93
Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg (1999) 2.57
Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg (1981) 2.53
A review and update on cholangiocarcinoma. Oncology (2004) 2.49
Cholangiocarcinoma. Clin Liver Dis (2008) 2.33
Preoperative portal vein embolization for extended hepatectomy. Ann Surg (2003) 2.33
Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg (1999) 2.24
Carcinoma of the hepatic hilus. Surgical management and the case for resection. Ann Surg (1979) 2.05
Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg (2003) 2.03
Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg (2003) 2.00
Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg (2008) 1.99
Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg (1998) 1.99
Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg (2004) 1.99
Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg (2004) 1.88
Carcinoma of the extrahepatic biliary tract. Ann Surg (1973) 1.86
Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg (1999) 1.83
Sclerosing carcinoma of the major intrahepatic bile ducts. AMA Arch Surg (1957) 1.82
Surgical management of hilar cholangiocarcinoma. Ann Surg (2005) 1.80
Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol (2006) 1.78
Surgical management of cholangiocarcinoma. Semin Liver Dis (2004) 1.75
Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg (2000) 1.71
Liver transplantation for cholangiocarcinoma. Transpl Int (2010) 1.58
Proximal bile duct cancer. Quality of survival. Ann Surg (1987) 1.54
Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery (2007) 1.54
Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK. Eur J Surg Oncol (2005) 1.49
Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery (1998) 1.47
Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant (2002) 1.41
The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer (1998) 1.38
Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford) (2005) 1.37
Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis (2004) 1.34
Surgical management of carcinoma of the junction of the main hepatic ducts. Ann Surg (1976) 1.25
Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome. World J Gastroenterol (2005) 1.17
Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg (2009) 1.15
Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg (2006) 1.10
Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol (2007) 1.09
Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB (Oxford) (2008) 1.05
Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg (2007) 1.03
Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg (2008) 1.02
Long-term survival after resection of proximal bile duct carcinoma (Klatskin tumors). World J Surg (1999) 1.00
Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival. J Am Coll Surg (2002) 0.97
Is preoperative biliary drainage necessary according to evidence-based medicine? J Hepatobiliary Pancreat Surg (2001) 0.96
Portal vein resection for hilar cholangiocarcinoma. Am Surg (2006) 0.91
Survival and an overview of decision-making in patients with cholangiocarcinoma. Hepatobiliary Pancreat Dis Int (2008) 0.89
Recent advances in the treatment of hilar cholangiocarcinoma: portal vein embolization. J Hepatobiliary Pancreat Surg (2007) 0.89
Portal vein embolization in hilar cholangiocarcinoma. Surg Oncol Clin N Am (2009) 0.88
Experience with more than 500 minimally invasive hepatic procedures. Ann Surg (2008) 3.23
Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg (2015) 2.36
Kidney transplantation alone in ESRD patients with hepatitis C cirrhosis. Transplantation (2012) 2.10
Laparoscopic major hepatectomy: an evolution in standard of care. Ann Surg (2009) 2.01
Laparoscopic liver resection: an examination of our first 300 patients. J Am Coll Surg (2011) 1.91
Hand transplantation in the United States: experience with 3 patients. Surgery (2008) 1.83
Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes. Ann Surg (2009) 1.74
Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004. Environ Health Perspect (2010) 1.48
Temporary silastic mesh closure for adult liver transplantation: a safe alternative for the difficult abdomen. Liver Transpl (2007) 1.40
Racial disparity in New Orleans: a faith-based approach to an age-old problem. Surgery (2012) 1.40
International experience for laparoscopic major liver resection. J Hepatobiliary Pancreat Sci (2014) 1.23
Increased biliary fistulas after liver resection with the harmonic scalpel. Am Surg (2003) 1.13
A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients. Surgery (2008) 1.08
Ultrasound monitoring of in vitro radio frequency ablation by echo decorrelation imaging. J Ultrasound Med (2008) 1.04
Toxicant-associated steatohepatitis in vinyl chloride workers. Hepatology (2010) 1.02
Is laparoscopic repeat hepatectomy feasible? A tri-institutional analysis. J Am Coll Surg (2011) 1.02
Laparoscopic left hemihepatectomy a consideration for acceptance as standard of care. Surg Endosc (2013) 1.01
Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study. Clin Transplant (2005) 1.00
Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature. J Heart Lung Transplant (2004) 0.99
MicroRNA gene expression signatures in the developing neural tube. Birth Defects Res A Clin Mol Teratol (2011) 0.98
A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients. Am J Surg (2008) 0.98
Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. Arch Dermatol (2011) 0.97
Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models. Antimicrob Agents Chemother (2013) 0.97
Developmental microRNA expression profiling of murine embryonic orofacial tissue. Birth Defects Res A Clin Mol Teratol (2010) 0.96
Laparoscopic hepatectomy is theoretically better than open hepatectomy: preparing for the 2nd International Consensus Conference on Laparoscopic Liver Resection. J Hepatobiliary Pancreat Sci (2014) 0.95
Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant (2005) 0.94
Perioperative anticoagulation and antiplatelet therapy in renal transplant: is there an increase in bleeding complication? Clin Transplant (2011) 0.93
No association between variant DNA repair genes and prostate cancer risk among men of African descent. Prostate (2010) 0.92
Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer. Dis Colon Rectum (2004) 0.92
Tumors and transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium. Am J Transplant (2003) 0.91
Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. Am J Transplant (2005) 0.90
Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients. J Am Coll Surg (2008) 0.88
What is the best technique in parenchymal transection in laparoscopic liver resection? Comprehensive review for the clinical question on the 2nd International Consensus Conference on Laparoscopic Liver Resection. J Hepatobiliary Pancreat Sci (2015) 0.88
MicroRNA expression profiling of the developing murine upper lip. Dev Growth Differ (2014) 0.87
A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Ann Surg Oncol (2008) 0.87
Posttransplant malignancy. Prog Transplant (2004) 0.87
Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry. Transplantation (2004) 0.87
An algorithm for the accurate identification of benign liver lesions. Am J Surg (2004) 0.86
Evaluation of a laparoscopic liver resection in the setting of cirrhosis. HPB (Oxford) (2013) 0.84
A novel classification system to address financial impact and referral decisions for bile duct injury in laparoscopic cholecystectomy. HPB Surg (2011) 0.84
Estimating key parameters in periodic breast cancer screening-application to the Canadian National Breast Screening Study data. Cancer Epidemiol (2010) 0.84
Laparoscopic Simultaneous Resection of Colorectal Primary Tumor and Liver Metastases: Results of a Multicenter International Study. World J Surg (2015) 0.83
Outcomes of laparoscopic and open resection for neuroendocrine liver metastases. Surgery (2012) 0.83
African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am J Transplant (2005) 0.83
Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage? Transpl Int (2011) 0.82
Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation (2002) 0.82
Lower levels of interleukin-12 precede the development of tuberculosis among HIV-infected women. Cytokine (2011) 0.81
Robotic liver resection: initial experience with three-arm robotic and single-port robotic technique. JSLS (2013) 0.81
Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation (2005) 0.81
Approaches to laparoscopic liver resection: a meta-analysis of the role of hand-assisted laparoscopic surgery and the hybrid technique. J Hepatobiliary Pancreat Sci (2015) 0.80
Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation. Transpl Int (2006) 0.79
Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma. J Surg Oncol (2014) 0.78
Laparoscopic liver surgery. Adv Surg (2009) 0.78
Treatment of an extracapsular post-renal biopsy pseudoaneurysm with ultrasound-guided thrombin injection. J Clin Ultrasound (2010) 0.78
MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature. Transplantation (2003) 0.77
Racial disparity and their impact on hepatocellular cancer outcomes in inner-city New Orleans. Surgery (2012) 0.77
Risk of cancer in liver transplant recipients: a look into the mirror. Liver Transpl (2008) 0.77
Review of the use of hepatitis B core antibody-positive kidney donors. Transplant Rev (Orlando) (2010) 0.77
The role of immunosuppression in lymphoma. Recent Results Cancer Res (2002) 0.76
Strain-specific modifier genes governing craniofacial phenotypes. Birth Defects Res A Clin Mol Teratol (2012) 0.76
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma. Transplantation (2004) 0.75
Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe? Transplantation (2009) 0.75
Environmental cigarette smoke exposure modulates IgE levels of Pb-exposed children. Toxicology (2011) 0.75
Laparoscopic hepatectomy under epidural anesthesia without general endotracheal anesthesia: feasible but applicable? Ann Surg (2014) 0.75
Temporal Expression of miRNAs in Laser Capture Microdissected Palate Medial Edge Epithelium from Tgfβ3(-/-) Mouse Fetuses. Microrna (2015) 0.75
The Israel Penn International Transplant Tumor Registry. AMIA Annu Symp Proc (2003) 0.75
United network for organ sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data. Transplantation (2005) 0.75
Efficacy of alvimopan following bowel resection: a comparison of two dosing strategies. Ann Pharmacother (2013) 0.75
Laparoscopic living kidney donation at a single center: an examination of donor outcomes with increasing experience. Am Surg (2011) 0.75
Kentucky pilot project for primary PCI without onsite CABG. J Ky Med Assoc (2009) 0.75
Liver transplantation for primary and metastatic hepatic malignancy: a single center experience. Surgery (2006) 0.75
Health status, perceptions and needs of Hispanics in rural Shelbyville, Kentucky. J Immigr Minor Health (2015) 0.75
Racial Disparity in Renal Transplantation: Alemtuzumab the Great Equalizer? Ann Surg (2015) 0.75
Malignancies in pediatric solid organ transplant recipients: epidemiology, risk factors, and prophylactic approaches. Curr Opin Organ Transplant (2010) 0.75